Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Rentschler Biopharma SE announced the appointment of Torsten Woehr as Chief Executive Officer (CEO), effective August 1, 2026.
read more
Monday, December 04, 2023
Rentschler Biopharma SE has announced the appointment of Dr. Günter Stempfer as the Site Head for the company's facility in Laupheim, Germany, effective December 1, 2023.
read more
Rentschler Biopharma SE announced the appointment of Dr. Dominik Kugelstadt as Head of Clinical and Commercial Manufacturing, Laupheim, on July 1, 2023.
read more
Wednesday, January 30, 2019
Rentschler Biopharma announced the appointment of Dr. Christian Hunzinger as the new Senior Vice President Project Management, effective from January 15, 2019.
read more
Monday, November 18, 2019
Rentschler Biopharma announced the hiring of two executives for its facility in Milford, MA, USA, in the greater Boston area.
read more
Thursday, January 22, 2026
Rentschler Biopharma SE announced that Detra Glinatsis has rejoined the company as Head of Business Development U.S. In this newly created role, Ms. Glinatsis will lead all business development activities related to the U.S. market. She reports to Dr...
read more
Wednesday, February 11, 2026
Rentschler Biopharma SE announced the appointment of Veit Bergendahl, PhD, as Chief Operating Officer (COO) and member of the Executive Board. He succeeds Christiane Bardroff, who has decided to pursue a new professional opportunity outside the ...
read more
Rentschler Biopharma appointed Mark Caswell as Vice President, Site Head. Mr. Caswell joined in July 2022 and is managing all operations at the company’s U.S. facilities in Milford, MA,
read more
Friday, November 03, 2023
Rentschler Biopharma SE, a contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals, has announced the promotion of Dr. Björn Beckmann to the position of Head of Quality Control at the Company's Laupheim site in ...
read more
Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the appointment of Dr. Robert Panting as General Manager of Rentschler ATMP[*] Ltd. This center of excellence is...
read more
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced the appointment of Dr. Martin Kessler as Chief Executive Officer (CEO) of Rentschler Biopharma Inc., the ...
read more
Tuesday, February 25, 2025
Rentschler Biopharma SE announced the promotion of Patrick Meyer, Ph.D., to Global Head of Business Development (BD), effective immediately.
read more
Tuesday, September 19, 2023
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced that the company has hired Benedikt von Braunmuehl as Chief Executive Officer (CEO).
read more
Rentschler Biopharma SE announced that Patrick Meyer, Ph.D., has been promoted to Global Head BD Sales and Alliance Management within the business development team, effective June 1, 2024. In this newly created position, Dr. Meyer will oversee global...
read more
Rentschler Biopharma SE announced that Patrick Cushing, Ph.D., has been promoted to Vice President Operations of Rentschler Biopharma, Inc., the company’s U.S. subsidiary, effective May 1, 2024. In this newly created position, Dr. Cushing will ...
read more